Viewing nowCombinationTeloditan Tablets 80/5mg
Telmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ilhwa Co., Ltd.

MFDS item code 201606395 · Approved 2016.10.31 · Insurance code 640903320
Treatment of essential hypertension not controlled with monotherapy
This medication is used in patients with primary hypertension who do not achieve sufficient blood pressure control with monotherapy of amlodipine or telmisartan.
The recommended dose is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take the tablet at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring caution during administration’). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
○ Children: This medicine is not recommended for pediatric patients 18 years of age or younger because its safety and efficacy have not been established.
This medication can cause serious risks to the fetus during pregnancy, especially in the second and third trimesters, and should not be taken by pregnant women or those who may become pregnant. This medication should not be administered to individuals allergic to the active ingredients or similar substances, patients with severe liver impairment, patients with severe hypotension, or patients with significant heart-related diseases. Patients with weakened liver function, gastrointestinal diseases, impaired kidney function, or elderly patients require special caution when using this medication. Side effects such as dizziness, swelling, and hypotension may occur when taking this medication, so if symptoms appear, consult a healthcare professional. Interactions may occur when taken with other blood pressure medications or certain drugs, so inform healthcare providers about any medications being taken. It is safer not to use this medication during pregnancy or lactation, and if pregnancy is confirmed, discontinue use immediately and consult with a healthcare provider. This medication is not recommended for children under 18 years of age, and dosage adjustments may be necessary for elderly patients, so caution is required. In case of overdose, serious symptoms such as hypotension, dizziness, and cardiac dysfunction may occur, so it is important to adhere to the prescribed dosage and contact healthcare professionals immediately if abnormal symptoms arise. This medication should be stored out of reach of children and kept in its original packaging to protect it from moisture and contamination.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that blocks light. Additionally, it is important to maintain a room temperature between 1 to 30 degrees Celsius when storing the medication. This helps preserve its effectiveness for a longer period.
White and light gray double-convex oval tablets
30 tablets/box [10 tablets/Alu-Alu X 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ilhwa Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.